SCHEMBL30194475

SCHEMBL30194475

CC(=O)O[C@@]12[C@H](O)[C@@H](C)[C@@]3(O)[C@@H](C=C(CO)C[C@]4(O)C(=O)C(C)=C[C@@H]34)[C@@H]1C2(C)C

nearest known ligand 0.83

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PRKCA P17252 5/20 0.71
▸ PRKD3 O94806 4/20 0.71
▸ PRKCG P05129 4/20 0.71
▸ PRKCB P05771 4/20 0.71
▸ PRKCH P24723 4/20 0.71
▸ PRKCI P41743 4/20 0.71
▸ PRKCE Q02156 4/20 0.71
▸ PRKCQ Q04759 4/20 0.71
▸ PRKCZ Q05513 4/20 0.71
▸ PRKCD Q05655 4/20 0.71
▸ PRKD1 Q15139 4/20 0.71
▸ USP2 O75604 2/20 0.71
▸ TP53 P04637 2/20 0.71
▸ KDM4E B2RXH2 1/20 0.71
▸ ALDH1A1 P00352 1/20 0.71
▸ SMN1; SMN2 Q16637 1/20 0.71
▸ CYP3A4 P08684 1/20 0.71
▸ CYP2C9 P11712 1/20 0.71
▸ TSHR P16473 1/20 0.71
▸ NFKB1 P19838 1/20 0.71

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL362736 1.00 PRKCA (0.71) PRKCAPRKD3PRKCGPRKCBPRKCH
SCHEMBL21981002 1.00 PRKCA (0.71) PRKCAPRKD3PRKCGPRKCBPRKCH
SCHEMBL18628313 1.00 PRKCA (0.71) PRKCAPRKD3PRKCGPRKCBPRKCH
SCHEMBL15423138 1.00 PRKCA (0.71) PRKCAPRKD3PRKCGPRKCBPRKCH
SCHEMBL18399929 1.00 PRKCA (0.71) PRKCAPRKD3PRKCGPRKCBPRKCH
SCHEMBL16922842 1.00 PRKCA (0.71) PRKCAPRKD3PRKCGPRKCBPRKCH
Ammonia Solution, Strong SCHEMBL5508975 0.99 PRKCA (0.70) PRKCAPRKD3PRKCGPRKCBPRKCH
SCHEMBL12925016 0.93 PRKCA (0.65) PRKCAPRKD3PRKCGPRKCBPRKCH
SCHEMBL18399927 0.93 PTGS2 (0.64) PRKCAPRKD3PRKCGPRKCBPRKCH
SCHEMBL15423106 0.93 PTGS2 (0.64) PRKCAPRKD3PRKCGPRKCBPRKCH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4304570-A2 COMPOSITIONS AND METHODS FOR TREATING ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) AND INFLAMMATORY DISORDERS CAUSED BY CORONAVIRUSES Phor-Med, Inc. (US) 2024-01-17 — — EP claimed
EP-4366837-A2 COMPOSITSONS AND METHODS FOR DECREASING PIGMENTATION The General Hospital Corporation (US) 2024-05-15 — — EP disclosed
WO-2023283554-A2 COMPOSITSONS AND METHODS FOR DECREASING PIGMENTATION THE GENERAL HOSPITAL CORPORATION (US) 2023-01-12 — — WO disclosed
Send feedback